Slide 1: Investor presentation: Results for the 12 months ending 31 May 2025
Connectivity that liberates healthcare Investor presentation Results for the 12 months ending 31 May 2025 Bleepa is a product by Feedback Medical | Feedback plc is a company registered in England and Wales Reg No: 00598696 | Reg Office: 201 Temple Chambers 3-7 Temple Avenue, London, EC4Y 0DT
Slide 2: Disclaimer
Disclaimer The information contained in this confidential document (the “Presentation”) and any information disclosed in any oral presentation thereof has been prepared by Feedback plc (the “Company”). It has not been fully verified and is subject to material updating, revision and further amendment
Slide 3: Operational highlights
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Operational highlights 1 £495k digital infrastructure contract with Queen Victoria Hospital NHS Foundation Trust Awarded further funding to extend the delivery of community diagnostic centre pathway pilot at the Northern Care Alliance site in
Slide 4: Financial highlights
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Financial highlights (all figures in £million) Revenue & Sales EBITDA loss Revenue: £0.89m (2024: £1.18m), down 25% due to the prior period including non-recurring revenue from the CDC pilot contracts and software development fees from Image
Slide 5: Meeting global healthcare challenges
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Meeting global healthcare challenges Clinical collaboration • Staffing Fixed • Premises supply costs Digital first • Legacy technology Asynchronous • Focus on cure not Outdated working practices Improved prevention productivity • Demographic
Slide 6: Bleepa is highly scalable with multiple routes to market
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Bleepa is highly scalable with multiple routes to market Routes to market UK Government and NHSE alignment • UK: NHS cross-provider care and NHS trusts and private sector • Bleepa perfectly aligned to the government’s 10 Year Health (TAM of £
Slide 7: Current status and next steps of key opportunities
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Current status and next steps of key opportunities Opportunity Key developments and current status Next steps 1. National • Submitted business case for a national Bleepa deployment • Continuing regular dialogue with DHSC and NHSE regarding di
Slide 8: Growth drivers
FEEDBACK PLC INVESTOR PRESENTATION Growth drivers 8
Slide 9: Alignment with UK Government priorities
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Alignment with UK Government priorities Reforming Elective Care Plan Darzi report 10 Year Health Plan for England Priority Alignment Priority Alignment Priority Alignment Straight-to-testBleepa enables clinically Analogue to Bleepa enables di
Slide 10: Transforming the outpatient model: asynchronous working
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Transforming the outpatient model: asynchronous working • 63% reduction in referral to treatment times (compared to national target) • 90% reduction in unnecessary outpatient appointments • 5x specialist productivity gains Overview • Bleepa p
Slide 11: Transforming the outpatient model: asynchronous working
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Transforming the outpatient model: asynchronous working Benefit for NHS • This model could mean a trust sees a 34% wait list reduction in-year if 50% of consultant programmed activity (PA) sessions were delivered asynchronously. • If adopted
Slide 12: Neighbourhood health: London-wide simulation
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Neighbourhood health: London-wide simulation Feedback Medical’s participation in the London Neighbourhood Health Service simulation is a strategic milestone. • Underscores Bleepa’s capability to operate effectively in large, complex healthcar
Slide 13: Partnerships: supporting growth
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Partnerships: supporting growth Implementation partner New territories Secure, with scaleable MedDream cloud/ viewer (USA, technology Canada) architecture Live view of GP record (integrations) TB screening programme (CSR funded) 13
Slide 14: Company and product overview
FEEDBACK PLC INVESTOR PRESENTATION Company and product overview 14
Slide 15: Internal priorities for external impact
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Internal priorities for external impact Focused, targeted, engaged Sales strategy Marketing strategy External affairs strategy • Data insights to identify targets • Stronger value propositions for • Increased engagement with • Focus on ideal
Slide 16: Product development: interoperability and useability
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Product development: interoperability and useability We invest in Bleepa’s capabilities to enhance scalability and user experience with a detailed road map for development. • eRS • Navigation • Live view hierarchy • GP Integrations Connect GP
Slide 17: Integration infrastructure
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Integration infrastructure eRS NHS trusts WEB DICOM GP APIs GP Connect PACS EPR HL7 RIS OPENID LIMS PAS Central NHS Entra/ NHSMail/ CIS2 PDS Single sign on 17
Slide 18: Strategic recognition for Feedback
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Strategic recognition for Feedback HSJ Partnership Awards Queen Victoria Hospital NHS Foundation Trust and Feedback Medical’s win at the HSJ Partnership Awards 2025 for Most Effective Contribution to Clinical Redesign underscores the commerci
Slide 19: Bleepa - asynchronous collaboration
BLEEPA® INVESTOR PRESENTATION Bleepa - asynchronous collaboration An asynchronous collaboration platform that unites essential data and teams to enhance clinical decision making. Features: • Referral management for inpatients/outpatients • Dashboard view for pathway management • Instant messaging fo
Slide 20: Competitor landscape
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Competitor landscape Data integration across care settings Clinical communication between settings and clinicians Ongoing remote Initial GP Triage/Referral First/follow up outpatient Diagnostic Speciality review via Clinical decision and pati
Slide 21: Regulatory accreditation
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Regulatory accreditation Our regulatory strategy a key differentiator in the market, assuring customers that our products meet the highest standards of quality, security, and compliance. We successfully achieve and maintain annually a compreh
Slide 22: Impact of Bleepa
BLEEPA® INVESTOR PRESENTATION Impact of Bleepa “If we think about it from an integrated neighbourhood care perspective, the ability for us to communicate in asynchronous ways through dependable platforms [like Bleepa] is going to be critical. “I think this is not just a fantastic way of redesigning
Slide 23: Outlook
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Outlook 1 Growing national and regional recognition of the need for our solution 2 Key focus on cross-provider care delivery in the UK with higher contract values and margins 3 Key focus on developing commercial partnerships to accelerate gro
Slide 24: Appendices
FEEDBACK PLC INVESTOR PRESENTATION Appendices 24
Slide 25: Feedback plc Board
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Feedback plc Board Prof Rory Shaw, Non-executive Dr Thomas Oakley, Chief Executive Chairman: Ex senior NHS executive, Officer: Qualified radiologist with Medical Director of Healthcare UK, Dept significant clinical and academic of Internation
Slide 26: Feedback Medical leadership team
FEEDBACK MEDICAL INVESTOR PRESENTATION Feedback Medical leadership team Dr Thomas Oakley, Chief Anesh Patel, Chief Financial Mike Hayball, Chief Technology Executive Officer: Qualified Officer: Chartered accountant with Officer: Medical imaging scientist radiologist with significant clinical signifi
Slide 27: Company history
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Company history 2025 • Provided Bleepa as digital platform for London-wide neighbourhood health simulation with PPL • Dr Tom Oakley announced as NHS Innovation Accelerator Fellow and Bleepa as innovation • 12-month contract with QVH/Sussex IC
Slide 28: ~£314m annual TAM estimated in UK
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 ~£314m annual TAM estimated in UK Company estimated total addressable market in the UK – annual 1 2 3 4 NHS NHS NHS Private Community TOTAL Trusts CDCs / ICS’ hospitals (UK) Pharmacies TAM £28m £81m £191m £14m £314m Note (1): Based on 229 NHS
Slide 29: Consolidated income statement
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Consolidated income statement FY 2025 FY 2024 £000 £000 Revenue 886 1,181 Cost of sales (107) (79) Gross profit 779 1,102 Other income 160 - Other operating expenses (5,149) (4,793) Operating loss (4,211) (3,690) Impairment of intangible asse
Slide 30: Consolidated balance sheet
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Consolidated balance sheet FY 2025 FY 2024 £000 £000 Property, plant and equipment 12 13 Intangible assets 564 4,068 Total non-current assets 576 4,081 Trade and other receivables 99 82 Corporation tax receivable 130 299 Cash and cash equival
Slide 31: Consolidated cashflow statement
FEEDBACK PLC INVESTOR PRESENTATION FULL YEAR RESULTS 2025 Consolidated cashflow statement FY 2025 FY 2024 £000 £000 Cash flows from operating activities Loss before tax (7,285) (3,597) Adjustments for: Net finance income (118) (93) Other Income - R&D tax credit (160) - Depreciation and amortisation
Slide 32: Get in touch today to find out how Feedback plc can work for you
Get in touch today to find out how Feedback plc can work for you: sales@fbkmed.com | feedbackmedical.com 32